Kaikai Yi
Tianjin Medical University Cancer Institute and Hospital(CN)National Clinical Research(US)
Publications by Year
Research Areas
Cancer-related molecular mechanisms research, MicroRNA in disease regulation, Extracellular vesicles in disease, RNA modifications and cancer, RNA Research and Splicing
Most-Cited Works
- → FUNDC1-dependent mitophagy induced by tPA protects neurons against cerebral ischemia-reperfusion injury(2020)188 cited
- → The CRISPR‐Cas13a Gene‐Editing System Induces Collateral Cleavage of RNA in Glioma Cells(2019)181 cited
- → Engineering blood exosomes for tumor-targeting efficient gene/chemo combination therapy(2020)158 cited
- → Dual‐Locking Nanoparticles Disrupt the PD‐1/PD‐L1 Pathway for Efficient Cancer Immunotherapy(2019)149 cited
- → Virus-like nanoparticle as a co-delivery system to enhance efficacy of CRISPR/Cas9-based cancer immunotherapy(2020)142 cited
- → The role of PTRF/Cavin1 as a biomarker in both glioma and serum exosomes(2018)121 cited
- → Blood exosomes-based targeted delivery of cPLA2 siRNA and metformin to modulate glioblastoma energy metabolism for tailoring personalized therapy(2022)111 cited
- → A Compound AC1Q3QWB Selectively Disrupts HOTAIR-Mediated Recruitment of PRC2 and Enhances Cancer Therapy of DZNep(2019)96 cited
- → Phosphatidylcholine‐Engineered Exosomes for Enhanced Tumor Cell Uptake and Intracellular Antitumor Drug Delivery(2021)74 cited
- → RUNX1 contributes to the mesenchymal subtype of glioblastoma in a TGFβ pathway-dependent manner(2019)71 cited